drug · small molecule
PRED MILD
updated 3mo agoby $ABBV AbbVie Inc.🔗 ChEMBL
community read0 votes
🐶 often sniffed alongside
top 3Small molecule drug with a maximum clinical stage of Approval (across all indications), with 5 approved and 11 investigational indications.
targets
Glucocorticoid receptor
all catalysts(0)
nothing on the calendar yet
Trials studying PRED MILD
- phase2A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression
- phase4Dextenza in the Post-op Management of Vitreoretinal Surgeries
- N/AEthanol Gel Versus Steroid in Refractory Lumbar Discogenic Pain
- phase3A Phase 3 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitis
- phase4In Clinic Optometrist Insertion of Dextenza Prior to Cataract Surgery
- phase4Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract
- phase2A Phase 2 Study of VVN461 Ophthalmic Solution for Noninfectious Anterior Uveitis
- phase3Clobetasol Propionate Ophthalmic Nanoemulsion, 0.05% in the Treatment of Inflammation After Cataract Surgery in Pediatric Population
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 8m ago
Found something off?
comments(0)
5-min edit window · permanent after that